D
elirium is an acute disturbance of consciousness and cognition that fluctuates in severity (1) . Also known as acute encephalopathy (2) , delirium occurs as many as eight of ten mechanically ventilated medical intensive care unit (ICU) patients. Although most clinicians consider ICU delirium an expected event that is iatrogenic and without consequence (3), it has recently been shown to be associated with increased length of stay, medical complications, and poor outcomes including increased mortality (4 -8) . What is not known, however, are the costs associated with the development of ICU delirium.
The ICU is an expensive part of the healthcare system, accounting for 1% of the annual U.S. gross domestic product (9) . The average cost of ICU care is estimated to be between $20,000 and $30,000 per patient (10 -12) . Some of the costs of critical care are due to complications such as ventilator-associated pneumonia (13, 14) and catheter-related bloodstream infection (15) . Because of the significant clinical and economic impact of these conditions, efforts have been made to identify risk factors for their development and interventions to reduce their incidence. On the other hand, little is known about the economic impact of delirium in critically ill patients, despite the fact that it occurs in the majority of those treated in the ICU (6, 7) . We conducted this investigation to determine the costs associated with delirium in mechanically ventilated medical ICU patients.
MATERIALS AND METHODS
Patients. The institutional review board approved this study, and informed consent was obtained from patients or their surrogate. Enrollment criteria included any adult, mechanically ventilated patient admitted to the medical or coronary ICUs of Vanderbilt University's 631-bed medical center from February 2000 to May 2001. During the study period, 555 mechanically ventilated patients were admitted to the ICU, of whom 275 (49.5%) were enrolled whereas 280 were excluded according to criteria defined a priori, including a history of psychosis or neurologic disease (e.g., cerebrovascular accident) (n ϭ 86), deafness or inability to understand English (n ϭ 13), extubation before enrollment (n ϭ 69), previously enrolled (n ϭ 27), patient or family refusal (n ϭ 41), or death before study nurses' assessments (n ϭ 44). Other data from this cohort of patients have been published as would be expected from prospective cohort investigations that have the capacity to address multiple issues. Specifically, data regarding the incidence of delirium in first 111 patients were published in the original Confusion Assessment Method for the ICU (CAM-ICU) validation article (6) and for the entire cohort in the Richmond AgitationSedation Scale (RASS) validation study (16) . Clinical outcomes data from this cohort, however, have only been published in abstract form (8) . All of the cost data in this report are entirely original and have not been previously published.
Study Protocol. Study nurses enrolled patients each morning and recorded baseline demographics including Acute Physiology and Chronic Health Evaluation II (17) , Sequential Organ Failure Assessment score (18, 19) , and Charlson Comorbidity Index (20) . Surrogate assessments were used to obtain baseline activities of daily living (21), visual and hearing deficits, and the modified Blessed Dementia Rating Scale (22) . Data regarding the presence of nosocomial infection (ventilator-associated pneumonia, catheter-related bloodstream infection, urinary tract infection, and other nosocomial infections) were collected prospectively by trained infection control nurses using Centers for Disease Control and Prevention National Nosocomial Infections Surveillance System criteria (23, 24) .
Delirium Assessment. Patients' daily cognitive status was defined as normal, delirious, or comatose using a combined neurologic assessment that took a median 1 min and objectively measured patients' arousal and delirium status. Arousal was measured using the Glasgow Coma Scale (25) and the RASS (16, 26) . Delirium was measured using the CAM-ICU (Table 1 ) (4, 6), a well-validated and highly reliable tool based on Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) criteria for delirium (27) . By definition, patients were delirious if they were responsive to verbal stimulation with eye opening and were CAM-ICU positive. Patients were defined as comatose if they a) responded only to physical/painful stimulation with movement but had no eye opening or ability to communicate; or b) had no response to verbal or physical stimulation. This definition of coma (28) corresponded to a median Glasgow Coma Scale of 4 out of possible 15 and a RASS of Ϫ4 or Ϫ5. Patients were considered normal if they were not delirious or comatose.
To examine cost differences between groups, patients were categorized by a) the clinical distinction of delirium "ever vs. never"; and b) a cumulative delirium severity index. The description of these schemes was as follows: Ever vs. never: If patients ever had delirium while in the ICU (i.e., CAM-ICU positive with a RASS level of Ϫ3 or higher), then they were categorized as "ever delirium." All others were categorized as "never delirium." Cumulative Delirium Severity Index: To stratify patients according to severity and duration of delirium, we assigned patients points for each daily assessment (Table 2) . On a given day, patients who were CAM-ICU negative received zero points whereas CAM-ICU-positive patients received between 1 and 6 points as determined by the absolute RASS score plus 1. In this way, patients with greater degrees of hyperactive or hypoactive delirium received incrementally greater points. Daily points were totaled to arrive at a cumulative delirium severity index. Patients with zero cumulative points were considered "normal." The remaining patients were grouped by tertiles of cumulative delirium severity (mild, moderate, or severe).
Cost Determination. Costs were determined from individual ledger-level patient charges using cost-center-specific cost-tocharge ratios and were reported in year 2001 U.S. dollars from the hospital perspective. Costs were defined as "ICU related" if they occurred on a day that the patient was in the ICU, with the exception of surgical and emergency department charges that occurred on the day of ICU admission. These exceptions and all other costs were classified as non-ICU related. Average cost per ICU day was calculated by dividing the total ICU cost by the ICU length of stay. ICU costs were further classified by grouping each ICU cost into clinically meaningful cost subcategories (i.e., bed expenses, pharmacy, laboratory, diagnostic radiology).
Statistical Analyses. Baseline characteristics were compared between patients who ever had delirium and never had delirium using Fisher's exact tests, Wilcoxon rank sum tests, or Student's t-tests as appropriate. Wilcoxon rank sum tests were also used to compare distributions of ICU cost, total hospital cost, and the duration of mechanical ventilation between those who did and did not develop delirium. Multiple linear regression was used to evaluate the association between delirium and cost after controlling for additional covariates. Because the ICU and total hospital cost data were skewed, the natural log transformation was taken of both response variables, a common practice in the analysis of cost data (29, 30) , after trimming exceedingly high total ICU costs (n ϭ 2) and total hospital costs (n ϭ 6) to $100,000 and $200,000, respectively. In this way, outlier patients had their maximum ICU and hospital costs trimmed for the multivariable analyses with assignment of $100,000 and $200,000, respectively. All multivariable analyses were adjusted for the following covariates, which were identified a priori as having possible confounding relationships with cost: age, gender, Charlson Comorbidity Index (20) , Acute Physiology and Chronic Health Evaluation II score (17), Sequential Organ Failure Assessment score (18, 19) , insurance status, race, HIV disease, renal failure, liver disease, congestive heart failure, alcohol abuse, drug abuse, malnutrition, sepsis, and nosocomial infection. One factor not chosen a priori, "surviving to hospital discharge," was added to the models following suggestion during peer review. Performing the analyses with or without this variable did not significantly change any of our results, and the current model includes this variable. Estimated ratios of unadjusted and adjusted cost for comparison groups with 95% confidence intervals were calculated. All p values reported are two-sided and all analyses were conducted using SAS release 8.02 (Cary, NC).
RESULTS
Patient Characteristics. Fifty-one of 275 patients (18.5%) had persistent coma and died in the hospital after a median of 8 (range, 4 -12) hospital days. Due to their 100% mortality rate and the inability to ever evaluate them for delirium, these persistent coma patients were not included in the remainder of the analyses. Of the remaining 224 patients, delirium developed in 183 (81.7%) for a median of 2.1 (interquartile range, 1-3) days. At enrollment there were no significant differences between the "ever delirium" and "never delirium" groups in terms of age, race, gender, severity of illness, degree of organ dysfunction, or admitting diagnosis (Table 3) . Patients who developed delirium had longer ICU (median, 8 vs. 5 days) and hospital length of stay (median, 21 vs. 11 days) (all p Ͻ .001).
Univariate Analysis of Cost. More than 395,000 individual line item charges were converted to costs and analyzed. Median (interquartile range) ICU and total hospital costs were $20,654 ($13,478 -$32,760) and $36,936 ($21,066 -$65,340), respectively. ICU costs (median, interquartile range) were significantly higher for patients with at least one episode of delirium ($22,346, $15,083-$35,521) compared with those who were never delirious ($13,332, $8,837-$21,471, p Ͻ .001, Fig. 1 ). Total hospital costs were also higher in those who developed delirium ($41,836, $22,782-$68,134) than in those who did not ($27,106, $13,875-$37,419, p ϭ .002). Delirious patients had significantly higher costs in most major Using the cumulative delirium severity index, we found that greater severity and duration of delirium were associated with significantly higher ICU and total hospital costs (Fig. 2) . No significant cost differences were found between those with a cumulative delirium severity classification of "normal" and those classified as "mild" (p ϭ .29, data not shown); therefore, the "normal" and "mild" categories were pooled. ICU costs (median, interquartile range) were greatest for those in the severe category ($34,330 
DISCUSSION
This is the first report of the costs associated with delirium in mechanically ventilated ICU patients. We have shown that the severity and duration of delirium were independently associated with increased ICU and total hospital costs. Even after we controlled for important potentially confounding variables, such as baseline comorbidities and severity of illness, we found that delirium was associated with a 1.4-fold and 1.3-fold increase in ICU and total hospital costs, respectively. In addition, the data demonstrated a "dose-response" in which cumulative delirium severity was associated with incrementally greater cost.
Delirium could be related to increased cost through a variety of mechanisms, such as greater severity of illness or degree of organ dysfunction (31-33), admitting diagnosis, or the presence of nosocomial infection (13) (14) (15) . However, inclusion of these variables in the multivariable analyses had little effect on the costs attributable to delirium. Another potential mechanism could be through increased intensity of resource use (34 -39) , although this seems unlikely given 
CAM-ICU, Confusion Assessment Method for the Intensive Care Unit; RASS, Richmond Agitation-Sedation Scale.
a Delirium severity index determination: Nondelirious (i.e., CAM-ICU negative) patients received zero delirium severity index points for a given day whereas delirious (i.e., CAM-ICU positive) patients received between 1 and 6 points on that day as determined by the absolute RASS score plus 1. In this way, patients with greater degrees of hyperactive or hypoactive delirium receive incrementally greater delirium severity index points. Daily points were then summed to arrive at a cumulative delirium severity index. (20) represents the sum of a weighted index that takes into account the number and seriousness of preexisting comorbidities; b Blessed Dementia Rating Scale (22) was validated as an instrument to be completed by surrogates to determine the presence of dementia. Scores range from 0 (best) to 17 (worst), with Ն4.5 representing the most widely used threshold for dementia; c activities of daily living scale (21) was completed by surrogates to estimate the baseline performance of the patient during the period just prior to the acute illness requiring admission to the intensive care unit. The scale ranges from 0 (best) to 12 (worst); d APACHE II (17) is a severity of illness scoring system, and these data were calculated using the most abnormal variables during the first 24 hrs following admission to the intensive care unit. APACHE II scores range from 0 (best) to 71 (worst); e SOFA (18, 19) is an organ failure scoring system that was also calculated using the most abnormal variables during the first 24 hrs following admission to the intensive care unit. SOFA scores range from 0 (best) to 24 (worst); f the admission diagnoses were recorded by the patients' medical team as the diagnoses most representative of the reason for ICU admission.
that there were no differences in cost per ICU day between delirious and nondelirious patient groups. A more plausible mechanism to explain the delirium-cost relationship is found in length of stay, which is known to be a major cost driver (12) and which was greater in delirious patients in our study. Because of the observational nature of this study, we cannot determine whether delirium caused longer lengths of stay or if longer lengths of stay simply resulted in greater time at risk for developing delirium. However, delirium could easily lead to increased length of stay and cost if it resulted in the administration of excess sedation or if it otherwise interfered with liberation from mechanical ventilation. The salient question is whether reducing the incidence and/or severity of delirium will alter clinical outcomes and improve cost. To address this question, future work should include trials of delirium prevention and treatment interventions that target modifiable risk factors such as sedation and analgesia practices (40) and early patient mobilization.
The associated annual cost of ICU delirium could be enormous. In our study, delirium occurred in 82% of mechanically ventilated patients and was associated with an incremental increase in ICU cost of $9,014 per patient. In the United States, there are approximately 880,000 -2,760,000 ICU admissions annually for respiratory failure requiring mechanical ventilation (41) (42) (43) (44) (45) . At the rate of delirium detected in our cohort, the estimated number of cases of ICU delirium could range from 721,600 to 2,263,200 per year with an associated increase in healthcare costs ranging between $6.5 and $20.4 billion. If we use the incidence of delirium from a less severely ill ICU cohort in which delirium occurred in only 19% of patients (46) , the estimated annual costs would still be in the range of $1.5-$4.7 billion. Since some of the additional cost associated with delirium in this study could be attributable to unmeasured differences between patient groups, these estimates represent the upper limit of the cost attributable to ICU delirium. If only 20% of the difference we noted was in fact due to delirium, then we would still find delirium to be a significant public health concern with $300 million to $4 billion in annual attributable costs. The strengths of this study include the prospective use of valid and reliable measures of levels of arousal and delirium that were specifically designed for mechanically ventilated patients and that are recommended for routine use in the ICU (47) . To determine costs, we used department-specific cost-to-charge ratios and detailed day-specific billing data. This approach has been shown to be accurate compared with even more rigorous costaccounting methodologies (38, 48) . Furthermore, since all costs were analyzed by the day in which they occurred, we were able to distinguish between ICUand non-ICU-related costs, something that many ICU cost studies have been unable to do.
Several limitations of this study are important to consider. The data obtained from this observational cohort study were not intended to establish a causal link between delirium and cost. In addition, this analysis was limited to the hospital perspective and therefore did not include physician fees or costs that occurred after discharge. Given emerging data suggesting that patients who experience ICU delirium may also have ongoing neurocognitive deficits and decreased long-term survival (8, 49 -52) , an analysis of the long-term societal costs of ICU delirium is warranted. Furthermore, this study was limited to medical ICU patients.
Whether these findings apply to other patient populations, such as surgical ICU patients, deserves additional study.
CONCLUSIONS
Delirium is a common clinical event in mechanically ventilated medical ICU patients and is independently associated with significantly higher ICU and hospital costs. These data underscore the importance of recent national recommendations for delirium assessment in all critically ill patients (47) . Future efforts to prevent or treat ICU delirium have the potential to improve patient outcomes and reduce costs of care.
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